From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...
Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results